Drug recall · February 1, 2017
Azelastine Hydrochloride Nasal Solution recall
Why: Defective Delivery System: out of specification result for droplet size distribution at the d90 measurement testing during the 6 month time point..
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Azelastine Hydrochloride Nasal Solution (Nasal Spray), 0.1% (137 mcg per spray), packaged in 30 mL bottles, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC 0054-0293-99
- Lots / codes
Lot # 659365A, Exp 3/31/2018
- Quantity
- 74,108 bottles
- Company
- Roxane Laboratories, Inc., Columbus, OH
- Distribution
- Nationwide and Puerto Rico.
- Initiated
- December 14, 2016 · Voluntary: Firm initiated
- Classified
- January 26, 2017
- Reported
- February 1, 2017
- Ended
- December 15, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Azelastine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.